HEAR FROM PEERS
Peer-to-peer learning hub
Improving Interstitial Lung Disease Diagnosis in a Multidisciplinary Discussion (MDD) Team Incorporating a Genomic Classifier
Listen to ILD experts provide an overview of their MDD and how the Envisia Genomic Classifier can be integrated into the ILD diagnostic algorithm. This ATS industry innovations webinar recording also includes a review and discussion of 3 real world cases in which the genomic classifier test impacted decision making.
72 year old active male with exertional dyspnea
Hear ILD pulmonologist experts discuss the diagnostic workup for this patient including how the Envisia Genomic Classifier impacted clinical decision making.
80 year old male with progressive shortness of breath
Hear ILD pulmonologist experts discuss the diagnostic workup for this patient including how the Envisia Genomic Classifier impacted clinical decision making.
61 year old female with worsening lung function
Hear ILD pulmonologist experts discuss the diagnostic workup for this patient including how the Envisia Genomic Classifier impacted clinical decision making.
Case Studies & Presentations
Envisia resource library
Watch case studies and testimonials from physicians or on-demand videos about Envisia and its clinical utility.
- POSTED ON
- Mar 26, 2021
Envisia Physician Testimonial
Detects genomic UIP pattern to improve ILD diagnostic confidence
Usual interstitial pneumonia (UIP) is a critical factor in differentiating idiopathic pulmonary fibrosis (IPF) from other interstitial lung diseases (ILDs). The Envisia classifier improves ILD diagnostic and prognostic confidence, and can identify twice as many UIP patients than radiology alone when combined with HRCT.